2,253 press releases in English indexed under biotech & pharma.
Common Stock Will Begin Trading on a Split-Adjusted Basis on October 26, 2026 BRANFORD, Conn., Oct. 16, 2026 -- Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced...
LEXINGTON, Mass., Oct. 16, 2026 -- Curis, Inc. (Nasdaq: CRIS) ("Curis" or the "Company"), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 and FLT3 inhibitor, today announced that it has entered into...
NEW YORK, Oct. 16, 2026 -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the fourth quarter of 2026 of $0.235 per Class A ordinary share.
PHILADELPHIA, October 16, 2026--Virion Therapeutics, LLC , a clinical-stage biotechnology company, developing T cell-based immunotherapies that contain checkpoint modifiers , today announced that an abstract reporting long-term follow-up data of VRON-0200, its novel, first-in-class, immunotherapy for
– Presentation will provide interim Phase 2 clinical data on HLX79/E-602, a first-in-class human sialidase enzyme therapeutic, in patients with membranous nephropathy – WALTHAM, Mass., October 16, 2026--Palleon Pharmaceuticals, a clinical-stage biotechnology company developing novel therapeutics for au
– Tom McCourt to Retire from CEO Post After 17 Years at Ironwood and Four Decades of Distinguished Industry Leadership Bringing Transformational Medicines to Patients – BOSTON, October 16, 2026--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a biotechnology company developing and commercializing life-
ST. PETERSBURG, Fla., Oct. 16, 2026 (SEND2PRESS NEWSWIZRE) -- While modern pediatric leukemia treatment stands as one of oncology's greatest triumph stories, a quiet and urgent crisis persists for adolescent and young adult (AYA) patients diagnosed with high-risk acute blood cancers. St. Petersburg-based Jackson Copeland Foundation targets the massive survival disparity gap in AYA acute myeloid leukemia, raising funds for pioneering research with Oct. 30 Anchors & Irons Invitational charity golf tournament in Clearwater.
As August workloads peak across New Mexico, Innovative Massage Therapy makes appointment-based therapeutic services available to clients throughout Albuquerque, Bernalillo County, Sandoval County, Rio Rancho, and Santa Fe. Albuquerque, NM, August 3, 2026 - The National Institute …
Dublin, Oct. 16, 2026 -- "Asthma Drugs Market by Mode of Administration; Medication; Application; Organization Type; Region - Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035" has been added to ResearchAndMarkets.com's offering.
Prioritize topoisomerase inhibitors, clinical ADCs, capacity expansion and strategic partnerships to capture rising precision oncology demand. Prioritize topoisomerase inhibitors, clinical ADCs, capacity expansion and strategic partnerships to capture rising precision oncology demand.
Extensive report evaluates the impact of advanced molecular diagnostics, changing U.S. Medicare fee schedules, and the "genetic blizzard" on hospital and laboratory testing demand. Extensive report evaluates the impact of advanced molecular diagnostics, changing U.S. Medicare fee schedules, and the "genetic blizzard" on hospital and laboratory testing demand.
Dublin, Oct. 16, 2026 -- "Germany Precision Oncology Diagnostics Market by Test Type (Companion Diagnostics, NGS-based Panels, Liquid Biopsy Tests, IHC / FISH-based Tests, PCR-based Tests), Type of Technology, Disease Indication, Sample Type, End User and Regional Hub - Trends and Forecast Till 2035" has been added to ResearchAndMarkets.com's offering.